Two weeks ago I traveled to Hyderabad, India, to attend the annual meeting of the Developing Country Vaccine Manufacturers Network (DCVMN).
This unusual alliance brings together vaccine companies in India, China, Brazil and a number of other mostly middle-income countries. Vaccine manufacturing in these countries is not new—many countries have long had factories, often state-owned, that produced basic vaccines for government immunization programs.
